Trinity Life Sciences Recapitalizes with Kohlberg & Company

Trinity Life Sciences signed a definitive agreement for a Kohlberg-led recapitalization following its partnership with Parthenon Capital. Trinity provides pharmaceutical commercialization services and data insights. The November 30, 2021 announcement was an agreement-stage event; the present portfolio directory confirms investment without independently establishing the exact legal close.